We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$9.39M
Cap. Flow
-$2.95M
Cap. Flow %
-2.64%
Top 10 Hldgs %
46.04%
Holding
65
New
4
Increased
20
Reduced
32
Closed
1

Top Buys

Rank Stock Value
1
IMPV
Imperva, Inc.
IMPV
+$834K
2
CYBR
CyberArk
CYBR
+$784K
3
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
+$735K
4
OCLR
Oclaro Inc.
OCLR
+$683K
5
CALD
Callidus Software, Inc.
CALD
+$619K

Top Sells

Rank Stock Value
1
AKRX
Akorn Inc
AKRX
+$2.38M
2
SPSC icon
SPS Commerce
SPSC
+$1.55M
3
XENT
Intersect ENT, Inc
XENT
+$1.16M
4
OMCL icon
Omnicell
OMCL
+$650K
5
ENZ
Enzo Biochem, Inc.
ENZ
+$405K

Sector Composition

Rank Sector Weight
1 Healthcare 48.56%
2 Technology 36.34%
3 Industrials 3.2%
4 Financials 2.81%
5 Miscellaneous 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCLR
1
DELISTED
Oclaro Inc.
OCLR
$8.82M 7.89%
944,066
+75,430
+9% +$683K
XENT
2
DELISTED
Intersect ENT, Inc
XENT
$8.44M 7.56%
301,963
-51,288
-15% -$1.16M
TLGT
3
DELISTED
Teligent, Inc
TLGT
$5.91M 5.29%
64,628
-2,658
-4% -$226K
SRGA
4
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$5.69M 5.1%
32,446
+5,164
+19% +$735K
FNSR
5
DELISTED
Finisar Corp
FNSR
$4.79M 4.29%
184,543
+4,818
+3% +$120K
NEO icon
6
NeoGenomics
NEO
$2.39B
$4.13M 3.7%
460,802
-34,080
-7% -$270K
AKRX
7
DELISTED
Akorn Inc
AKRX
$3.95M 3.54%
117,837
-72,956
-38% -$2.38M
CALD
8
DELISTED
Callidus Software, Inc.
CALD
$3.42M 3.06%
141,436
+28,580
+25% +$619K
OMCL icon
9
Omnicell
OMCL
$1.52B
$3.15M 2.82%
72,967
-15,650
-18% -$650K
CVLT icon
10
Commault Systems
CVLT
$5.82B
$3.12M 2.8%
55,326
+1,327
+2% +$72.6K
IDTI
11
DELISTED
Integrated Device Technology I
IDTI
$3.03M 2.71%
117,526
-1,751
-1% -$42.6K
GIMO
12
DELISTED
Gigamon Inc.
GIMO
$3M 2.69%
76,272
-1,540
-2% -$58K
ATRC icon
13
AtriCure
ATRC
$2.51B
$2.83M 2.54%
116,894
-1,920
-2% -$40.8K
NXTM
14
DELISTED
NxStage Medical Inc.
NXTM
$2.75M 2.46%
109,546
-8,233
-7% -$204K
LGND icon
15
Ligand Pharmaceuticals
LGND
$5.67B
$2.72M 2.44%
35,933
-1,840
-5% -$129K
SWKS icon
16
Skyworks Solutions
SWKS
$10.1B
$2.62M 2.35%
27,324
-452
-2% -$46.4K
KTWO
17
DELISTED
K2M Group Holdings, Inc
KTWO
$2.45M 2.19%
100,503
-3,386
-3% -$75.3K
IMPV
18
DELISTED
Imperva, Inc.
IMPV
$2.43M 2.18%
50,789
+17,887
+54% +$834K
PODD icon
19
Insulet
PODD
$9.95B
$2.34M 2.1%
45,663
-628
-1% -$27.3K
EGHT icon
20
8x8 Inc
EGHT
$290M
$2.22M 1.99%
152,795
-2,305
-1% -$32.7K
CYBR
21
DELISTED
CyberArk
CYBR
$2.21M 1.97%
44,143
+15,527
+54% +$784K
ENZ
22
DELISTED
Enzo Biochem, Inc.
ENZ
$2.2M 1.97%
199,132
-43,508
-18% -$405K
QRVO icon
23
Qorvo
QRVO
$8.49B
$2.07M 1.85%
32,644
-521
-2% -$37.3K
SUPN icon
24
Supernus Pharmaceuticals
SUPN
$2.57B
$1.97M 1.77%
45,782
-773
-2% -$27.5K
MXL icon
25
MaxLinear
MXL
$5.75B
$1.82M 1.63%
65,212
-1,338
-2% -$39K
1
2 3

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Kopp Investment Advisors held 65 positions worth $112M, up 9.2% from $102M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Kopp Investment Advisors's Q2 2017 filing shows 4 new, 20 increased, 32 reduced and 1 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 22,135 shares worth $263K. The largest sale was Akorn Inc, an estimated $2.38M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 46% a quarter earlier, followed by Technology and Industrials.

  • Kopp Investment Advisors's largest Q2 2017 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 22,135 shares worth $263K.
  • Kopp Investment Advisors added most to Imperva, Inc. in Q2 2017, an estimated $834K increase.
  • Kopp Investment Advisors's biggest Q2 2017 reduction was Akorn Inc, cutting an estimated $2.38M.
  • Kopp Investment Advisors fully exited SPS Commerce in Q2 2017, selling an estimated $1.55M.
  • Kopp Investment Advisors's ten largest holdings make up 46% of its $112M portfolio in Q2 2017.
  • Kopp Investment Advisors opened 4 new positions and closed 1 in Q2 2017.
  • Kopp Investment Advisors's portfolio value rose 9.2% quarter-over-quarter to $112M.

Based on Kopp Investment Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.